BOSTON SCIENTIFIC CORPORATION Foreign Currency Transaction Gain (Loss), before Tax
BOSTON SCIENTIFIC CORPORATION (BSX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$13.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2017-02-23
- BOSTON SCIENTIFIC CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2016 was -$13.00M.
- BOSTON SCIENTIFIC CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2015 was -$21.00M.
- BOSTON SCIENTIFIC CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2014 was -$18.00M.
- BOSTON SCIENTIFIC CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2013 was -$11.00M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|
| 2016-12-31 | -$13.00M 10-K · filed 2017-02-23 | |
| 2015-12-31 | -$21.00M 10-K · filed 2017-02-23 | |
| 2014-12-31 | -$18.00M 10-K · filed 2017-02-23 | |
| 2013-12-31 | -$11.00M 10-K · filed 2016-02-24 | |
| 2012-12-31 | -$18.00M 10-K · filed 2015-02-25 | |
| 2011-12-31 | -$12.00M 10-K · filed 2014-02-26 | |
| 2010-12-31 | -$9.00M 8-K · filed 2013-05-29 | $9.00M 10-K · filed 2012-02-17 |
| 2009-12-31 | -$5.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |